高级检索
当前位置: 首页 > 详情页

Associations of LIM kinase1 (LIMK1) gene single nucleotide polymorphisms with prostate cancer susceptibility in Chinese population.

| 认领 | 导出 |

文献详情

资源类型:
Pubmed体系:
机构: [1]Institute of Urology, Department of Urology, West China Hospital, Sichuan University, Chengdu, China [2]Department of Vascular Surgery, West China Hospital, Sichuan University, Chengdu, China [3]Department Liver Surgery,West China Hospital, Sichuan University, Chengdu, China [4]Department Oncology, West China Hospital, Sichuan University, Chengdu, China [5]Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education, Chengdu, China [6]Department of Pediatrics, West China Second University Hospital, Sichuan University, Chengdu, China
出处:

关键词: Prostate cancer cancer risk LIM kinase1 (LIMK1) single nucleotide polymorphism gene variant

摘要:
Prostate cancer is one of the most common cancers in men. LIM kinase1 (LIMK1) is a mediator in the process of cytoskeleton reorganization and cell motility. LIMK1 is related to progression, invasiveness and metastases of prostate cancer. However, the relationship between LIMK1 single nucleotide polymorphism (SNP) and the risk of prostate cancer has not been studied. The aim of our study is to determine the association between LIMK1 polymorphisms and the risk of prostate in a Chinese population. This case-control study consisted of 162 prostate cancer patients and 187 healthy control subjects. Five SNPs of LIMK1 including rs2269082, rs2269081, rs178409, rs6460071 and rs710968 were genotyped using iPLEX genotyping assays on a MassARRAY® platform. No significant relationships were found between polymorphisms genotypes and the risk of prostate cancer. Also, no significant associations were found between genotypes and the individual factors such as Gleason Score, alcohol and cigarette consuming statuses. These polymorphisms of LIMK1 were not significantly associated with prostate cancer susceptibility in Chinese men. IJCEP Copyright © 2017.

基金:
语种:
PubmedID:
中科院(CAS)分区:
出版当年[2017]版:
大类 | 4 区 医学
小类 | 4 区 肿瘤学 4 区 病理学
最新[2023]版:
第一作者:
第一作者机构: [1]Institute of Urology, Department of Urology, West China Hospital, Sichuan University, Chengdu, China
通讯作者:
通讯机构: [5]Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education, Chengdu, China [6]Department of Pediatrics, West China Second University Hospital, Sichuan University, Chengdu, China [*1]Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Edu-cation, Chengdu, China [*2]Department of Pediatrics, West China Second University Hospital, Sichuan University, Chengdu, China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:43370 今日访问量:0 总访问量:3120 更新日期:2024-09-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 四川省肿瘤医院 技术支持:重庆聚合科技有限公司 地址:成都市人民南路四段55号